Gary tin-ho Lee1, Jess lam-ming Leung. 1. Department of Psychiatry, United Christian Hospital, Hong Kong. Electronic address: leetinho@hotmail.com.
Abstract
OBJECTIVE: Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is not uncommon in patients receiving treatment of selective serotonin reuptake inhibitors or venlafaxine. METHOD: This is a case report of a 47-year-old man with depression, who developed hyponatremia after commencing treatment with desvenlafaxine. RESULTS: To our knowledge, this is the first case in which desvenlafaxine-associated SIADH was reported since the introduction of the drug. CONCLUSION: Physicians should be aware of the possibility of desvenlafaxine-associated hyponatremia in patients under age of 65.
OBJECTIVE:Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is not uncommon in patients receiving treatment of selective serotonin reuptake inhibitors or venlafaxine. METHOD: This is a case report of a 47-year-old man with depression, who developed hyponatremia after commencing treatment with desvenlafaxine. RESULTS: To our knowledge, this is the first case in which desvenlafaxine-associated SIADH was reported since the introduction of the drug. CONCLUSION: Physicians should be aware of the possibility of desvenlafaxine-associated hyponatremia in patients under age of 65.